PIA
ASMB icon

Piedmont Investment Advisors’s Assembly Biosciences ASMB Stock Holding History

Piedmont Investment Advisors’s Portfolio ASMB Stock Details ASMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-25
Closed -$12K – 1121
2018
Q2 		$12K Buy
+25
New +$13.2K ﹤0.01% 1754

Other funds holding ASMB

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Piedmont Investment Advisors's ASMB Position: Q3 2018 in Review

Piedmont Investment Advisors sold out of Assembly Biosciences (ASMB) in Q3 2018, closing a stake of 25 shares — an estimated $12K sold.

Piedmont Investment Advisors first reported a position in ASMB in Q2 2018 and held it in 1 quarter. The position peaked at $12K in Q2 2018. 113 funds tracked by Wall St. Rank hold ASMB as of Q3 2018.

  • Piedmont Investment Advisors reported no remaining Assembly Biosciences position as of Q3 2018 after selling out during the quarter.
  • Piedmont Investment Advisors sold 25 Assembly Biosciences shares in Q3 2018, an estimated $12K.
  • Piedmont Investment Advisors first reported a position in Assembly Biosciences in Q2 2018 and held it in 1 quarter.
  • Piedmont Investment Advisors's Assembly Biosciences position peaked at $12K in Q2 2018.
  • 113 funds tracked by Wall St. Rank held Assembly Biosciences as of Q3 2018.

Based on Piedmont Investment Advisors's 13F filing for Q3 2018, filed 8 Nov 2018.